dr. jahanzeb discusses advancements in adjuvant her2 breast cancer
Published 6 years ago • 61 plays • Length 1:53Download video MP4
Download video MP3
Similar videos
-
2:06
dr. jahanzeb on the aphinity and extenet trials in breast cancer
-
2:02
chemotherapy with adjuvant therapy in breast cancer
-
2:09
adjuvant therapy data for her2-positive breast cancer
-
1:02
dr. mohammad jahanzeb on neratinib and trastuzumab in her2-positive breast cancer
-
2:35
dr. jahanzeb on overcoming her2 resistance in breast cancer
-
1:46
dr. esteva discusses adjuvant trastuzumab in her2 breast cancer
-
2:51
breast cancer: extended adjuvant therapy and cost factors
-
1:19
dr. jahanzeb on the benefit of pertuzumab plus trastuzumab in her2 breast cancer
-
1:13
dr. pegram discusses adjuvant pertuzumab in her2 breast cancer
-
0:53
dr nanda on treatment de-escalation in her2 breast cancer and tnbc
-
8:21
extended adjuvant therapy for her2-positive breast cancer
-
1:18
dr. hamilton discusses the katherine trial in her2 breast cancer
-
1:37
dr. mitri discusses adjuvant therapy for her2 breast cancer
-
1:44
dr. kass discusses her2-positive breast cancer advancements
-
1:44
breast cancer: factors to consider for adjuvant therapy
-
1:45
dr. sramila aithal describes the herceptin adjuvant (hera) trial for her2-positive breast cancer
-
1:25
dr. tolaney on the neoadjuvant therapy for her2-positive breast cancer
-
1:53
dr. hamilton on adjuvant therapy for her2 breast cancer
-
2:36
dr. blackwell discusses tucatinib in her2 breast cancer